SCHEMBL17345892

SCHEMBL17345892

CCC(C)N(CC)CCNCCSCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.39
HPGD P15428 4/20 0.39
LMNA P02545 4/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
MAPT P10636 3/20 0.38
POLB P06746 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
HTT P42858 3/20 0.35
CYP2C19 P33261 3/20 0.35
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2D6 P10635 2/20 0.34
CYP2C9 P11712 2/20 0.34
KDM4E B2RXH2 2/20 0.34
PKM P14618 1/20 0.34
GAA P10253 1/20 0.34
ALOX12 P18054 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17346376 0.92 ALDH1A1 (0.39) ALDH1A1HPGDLMNASMN1; SMN2KMT2A
SCHEMBL17346060 0.91 OPRK1 (0.41) ALDH1A1HPGDLMNASMN1; SMN2KMT2A
SCHEMBL17345891 0.89 MEN1 (0.42) ALDH1A1HPGDLMNASMN1; SMN2KMT2A
SCHEMBL17346381 0.89 SIGMAR1 (0.38) ALDH1A1HPGDLMNASMN1; SMN2KMT2A
SCHEMBL17346239 0.87 CHRM2 (0.36) ALDH1A1HPGDLMNASMN1; SMN2KMT2A
SCHEMBL17346167 0.86 ALDH1A1 (0.40) ALDH1A1HPGDLMNASMN1; SMN2KMT2A
SCHEMBL17345879 0.85 SIGMAR1 (0.40) ALDH1A1HPGDLMNASMN1; SMN2KMT2A
SCHEMBL17346360 0.85 MEN1 (0.41) ALDH1A1HPGDLMNASMN1; SMN2KMT2A
SCHEMBL17346377 0.84 MEN1 (0.40) ALDH1A1HPGDLMNASMN1; SMN2KMT2A
SCHEMBL17346109 0.84 OPRK1 (0.35) ALDH1A1HPGDLMNASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis TRIAD NATIONAL SECURITY, LLC (US) 2020-02-04 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
WO-2015191505-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS LOS ALAMOS NATIONAL SECURITY, LLC (US) 2015-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS NANS, NCL, NCLN ALDH1A1 862/4885HPGD 973/4885LMNA 3058/4885
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis NANS, NCL, NCLN ALDH1A1 862/4885HPGD 973/4885LMNA 3058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.